Millions could gain easier access to popular peptides after FDA panel vote

An FDA panel voted to recommend that six peptides, including BPC-157, TB-500, and KPV, be available for compounding by licensed pharmacies. The vote allows these substances to be prepared by regulated facilities rather than obtained through unlicensed vendors. The recommendation moves to the FDA for final review.

Next story